KARD$15.004.75%0.68
After Hours: 14.32-0.68 -4.53%
Kardigan Inc (KARD)
Date: 2026-11-04 16:00O: 15.24H: 15.59L: 14.40C: 15.56Vol: 490.8k
Kardigan Inc stock is traded at $15.00, with a volume of 110,909. It is up +4.75% in the last 24 hours and up +1.42% over the past month. Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Previous Close:
$14.32
Open:
$15.24
24h Volume:
110,909
Relative Volume:
0.24
Market Cap:
$1.40B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.25%
1M Performance:
+1.42%
6M Performance:
0.00%
1Y Performance:
0.00%
1-Day Range:
$14.40$15.41
1-Week Range:
$13.53$15.59
52-Week Range:
$12.23$27.00
Kardigan Inc Stock (KARD) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS
Kardigan Inc Stock (KARD) Upgrades & Downgrades
Kardigan Inc Stock (KARD) Financials Data
There is no financial data for Kardigan Inc (KARD). Check out other stocks for more information.
Kardigan Inc Stock (KARD) Insider Trading
- BERNS PAUL LJun 22 '26Director
- Transaction
- Buy
- Cost
- $16.00
- #Shares
- 1,250,000
- Value ($)
- 20,000,000
- #Shares Total
- 15,042,035
- ARCH Venture Partners XIII, LLJun 22 '26Director
- Transaction
- Buy
- Cost
- $16.00
- #Shares
- 1,250,000
- Value ($)
- 20,000,000
- #Shares Total
- 15,042,035
- HRTG GPE, LLCJun 22 '2610% Owner
- Transaction
- Buy
- Cost
- $16.00
- #Shares
- 3,125,000
- Value ($)
- 50,000,000
- #Shares Total
- 14,866,868
